Do not use to diagnose Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.1 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimen plainly as "acute" or "convalescent."
Contaminated or heat-inactivated specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year
Effective February 16, 2021
|0.7 U/L or less||Not Detected|
|0.8-1.2 U/L||Indeterminate - Repeat testing in 10-14 days may be helpful.|
|1.3 U/L or greater||Detected|
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0051626||EBV Antibody To Viral Capsid Antigen IgA||31369-2|
- EBV Antibodies
- EBV VCA-IgA Ab
- Infectious Mononucleosis